(Q24203712)

1

0 references

Claire Jenkinson

2

0 references

Rosemary Humphreys

3

0 references

Hywel C Williams

Cochrane Database of Systematic Reviews

4

0 references

language of work or name

English

0 references

publication date

15 February 2012

0 references

published in

0 references

issue

2

0 references

page(s)

CD005205

0 references

cites work

Efficacy of dietary hempseed oil in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Postnatal somatic and mental development after periconceptional multivitamin supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Delay of growth and development in children with bronchial asthma, atopic dermatitis and allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Allergen sensitization through the skin induces systemic allergic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Oral evening primrose oil and borage oil for atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Probiotics for treating eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Genetics and genomics of asthma and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Severity distribution of atopic dermatitis in the community and its relationship to secondary referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

How atopic is atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Administration of oral vitamin D induces cathelicidin production in atopic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Pandemic of atopic diseases--a lack of microbial exposure in early infancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Cost of illness of atopic dermatitis in children: a societal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Pharmacoeconomics of drug therapy for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

The socioeconomic impact of atopic dermatitis in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Maternal B vitamin intake during pregnancy and wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

The interaction between particulate air pollution and allergens in enhancing allergic and airway responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Controversy in Counting and Attributing Events in Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

What are the best outcome measurements for atopic eczema? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Vitamin D in atopic dermatitis, asthma and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Treatment principles of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

The cost of atopic dermatitis in the Netherlands: an international comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Evening primrose oil for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Is eczema really on the increase worldwide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

Effects of linoleic acid supplements on atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Effect of dietary supplementation with sea buckthorn (Hippophaë rhamnoides) seed and pulp oils on the fatty acid composition of skin glycerophospholipids of patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Effects of dietary supplementation with sea buckthorn (Hippophaë rhamnoides) seed and pulp oils on atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Measurement of disease activity and outcome in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

The cost of atopic eczema.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Pyridoxine in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Effect of n-3 fatty acid supplement to patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

The effect of supplementation with selenium and vitamin E in psoriasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

Systematic review of treatments for atopic eczema.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005205.PUB3

7 January 2021

10.1002/14651858.CD005205.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1961200

1961200

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference